GDTC CytoMed Therapeutics: Company Short-Term Debts

Symbol and logo of brand CytoMed (GDTC)

Short-term loans and credits for CytoMed Therapeutics (GDTC) on GURU.Markets indicate a risk of cash flow gaps, with the indicator measuring 0.00, which complements the strategy of CytoMed Therapeutics to optimize cryogenic therapy supplies. The high scaling potential of modified cells enables global market expansion at low costs. The stability of the biotech potential is supported by a strong staff of immunologists and the recruitment of clinical trial experts.

GDTC w2.cytomed.sg Company Short-Term Loans and Borrowings (02/21/2024 - 10/30/2026)

GDTC (CytoMed Therapeutics Ltd): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price CytoMed|GDTC - Consensus Target
- company stock capitalization data:
Market Capitalization CytoMed Therapeutics Limited|GDTC - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share CytoMed Therapeutics|GDTC - Accounting Value of Company|Market Cap to Net Assets Ratio w2.cytomed.sg|GDTC - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital CytoMed Therapeutics|GDTC - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio CytoMed|GDTC - Company Aggregate Debts|Debt to Book Capitalization Ratio CytoMed Therapeutics Limited|GDTC - Company Long-Term Loans and Borrowings|Company Short-Term Debts CytoMed Therapeutics|Quick Ratio w2.cytomed.sg
- earnings and multiples data:
GDTC - Net Income
Analysis of all company metrics:GDTC - w2.cytomed.sg
Manufactured products of CytoMed Therapeutics

This metric measures the total volume of short-term borrowings, determining the extent of the business's liquidity dependence on external creditors and its ability to cover operating expenses. Regular monitoring of short-term liabilities allows for an assessment of the efficiency of capital management, which CytoMed Therapeutics (GDTC) directs toward scaling the automated production of cell therapy within closed robotic systems.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debts CTOR|Company Current Liabilities tuhurabio.com HURA|Protara Therapeutics, Inc. - Company Current Liabilities|Fate Therapeutics Inc (FATE) - Short-Term Debt|WHWK: Company Current Liabilities|TScan Therapeutics - Amount of Current Liabilities|championsoncology.com (CSBR) - Company Short-Term Debt|Short-Term Debt XBiotech (XBIT)|Company Short-Term Debt CEL-SCI Corp.|Company Current Liabilities OS Therapies Inc. (OSTX)|Company Short-Term Debts RADX|ARTV - Short-Term Debt|Company Short-Term Debts ANL (Adlai Nortye)|VERU: Company Short-Term Indebtedness|TPST: Company Current Liabilities|Company Short-Term Loans and Borrowings XLO (Xilio Therapeutics, Inc.)|RENB (renovarobio.com) - Company Current Liabilities|MURA: Amount of Current Liabilities|KAPA (Kairos Pharma Limited) - Company Short-Term Debts|OKUR: Company Short-Term Loans and Borrowings|Company Short-Term Debts CRIS|APLM - Short-Term Debt|Company Short-Term Debt Tharimmune Corp THAR|Company Short-Term Loans and Borrowings ADVB|Genprex, Inc. - Company Short-Term Debts|CLDI - Company Short-Term Debts|Sunshine Biopharma (SBFM) - Company Short-Term Debt|Current Liabilities XBIO (Xenetic Biosciences, Inc.)|SLRX (Salarius) - Company Short-Term Debts|Short-Term Debt Kitov Pharma PPBT|Company Current Liabilities AONC (American Oncology Network)|Company Short-Term Debts beigene.com (BGNE)|Checkpoint Therapeutics, Inc. - Company Current Liabilities|Amount of Current Liabilities ELEV (Elevation Oncology Inc.)|iCAD Corp - Company Short-Term Debts|Short-Term Debt Volume Ikena Oncology, Inc. IKNA|NTBL: Company Short-Term Debts|Company Current Liabilities Viracta Therapeutics, Inc.|Company Short-Term Debt MorphoSys|NAYA Biosciences Inc (NAYA) - Short-Term Debt Volume|Company Short-Term Debts AAPGV